Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent <i>Clostridioides difficile</i> Infection

Recurrent <i>Clostridioides difficile</i> infections (rCDI) have a substantial impact on healthcare systems, with limited and often expensive therapeutic options. Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the adult population and is associated with metabolic syndrome,...

Full description

Bibliographic Details
Main Authors: Lara Šamadan, Mia Jeličić, Adriana Vince, Neven Papić
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antibiotics
Subjects:
CDI
Online Access:https://www.mdpi.com/2079-6382/10/7/780